This firm fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Administration to Whitehouse Analytical Laboratories LLC, a subsidiary of Curia Global Inc. (doing business as Amri), for a VIAL STUDY. The award has a potential value of $116,205.00 and a completion date of May 27, 2017. Curia Global Inc. is a leading contract development and manufacturing organization that provides a wide range of pharmaceutical research...
This is a $61,550 firm-fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 20 to Curia Bio Inc. for material generation and molecular evaluation of three human monoclonal antibodies with therapeutic potential. The contract, which does not have a set-aside designation, requires the contractor to perform comprehensive in silico developability assessment, biophysical profiling, and multi-attributed...
This is a delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Curia Global Inc., doing business as Amri, for $218,000.00 in nonclinical services to support the development of interventional agents for infectious diseases. The contract is not set aside. Curia is a leading global contract development and manufacturing organization that provides a wide range of services from drug...
This federal contract award was made by a U.S. government agency to Curia Global Inc., doing business as Amri, for the provision of laboratory equipment and supplies. The $5,800.00 purchase order did not have a set-aside designation. Curia is a leading global contract development and manufacturing organization (CDMO) that provides a wide range of services from drug discovery through commercialization to pharmaceutical and biotech companies. Through this and numerous other prime and subcontract...
This is a $110,987.74 firm-fixed price purchase order awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 6 to Assured Bio Labs, LLC, a certified woman-owned small business, to provide pharmaceutical aseptic and environmental testing services. The contract has an ultimate completion date of April 30, 2028. This is a follow-on contract to previous awards Assured Bio Labs has received from the VA and the Department of Health and Human Services...
This is a $98,253.09 firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 4 (VISN 4) of the U.S. Department of Veterans Affairs (VA) to CDI Laboratories Inc., a small disadvantaged business manufacturer. The contract is for the provision of CDI's HuProt v4.0 Human Proteome Microarray, containing over 21,000 human proteins, as well as its VirScan viral antibody profiling and immuneprofiler antibody analysis services. This work supports biomedical research efforts,...
This federal contract award is for Task C03 under the Nonclinical Services for Development of Interventional Agents contract, a delivery order awarded to Curia Global Inc., doing business as Amri. Amri is a leading contract development and manufacturing organization (CDMO) that provides a wide range of pharmaceutical research and development services to federal agencies, particularly the National Institutes of Health (NIH) and its institutes. The award has a total ceiling value of $860,162.70...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $554,127.00 Cost Plus Fixed Fee contract to Curia Global Inc., doing business as Amri, for the "SCALE UP FERMENTATION AND ISOLATION OF MEDINAMYCIN" effort. This is a Delivery Order issued under the Nonclinical Services for Development of Interventional Agents indefinite-delivery, indefinite-quantity (IDIQ) contract. Curia Global is a leading global...
This is a delivery order under indefinite-delivery/indefinite-quantity (IDIQ) contract HHSN271201800001I awarded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), to Curia Global Inc. (doing business as Amri). The $1,796,372.11 contract is for "HIT TO LEAD CHEMISTRY UNDER PERFORMANCE AREA 2" of the Medicinal Chemistry Support Program for Therapeutic Development. Curia, a leading global contract development and...
This is a delivery order contract awarded by the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) to Curia Global Inc., doing business as Amri, for the Medicinal Chemistry Support Program for Therapeutic Development. The contract, with a potential value of $4,042,434.33, provides chemistry, manufacturing, and controls development; exploratory chemistry; hit-to-lead chemistry; absorption/distribution/metabolism/excretion testing; process...